Indolinone based phosphoinositide-dependent kinase-1 (PDK1) inhibitors. Part 2: optimization of BX-517.
暂无分享,去创建一个
M. Adler | M. Whitlow | R. Feldman | G. Phillips | M. Polokoff | Greg Brown | I. Islam | Shendong Yuan | Judi A. Bryant | E. Ho | James M. Wu | M. Kochanny | D. Zhu | D. Lentz | D. Arnaiz | Paul Hrvatin | B. Subramanyam | J. Walters | Jun Shen | Daguang Zhu | Dao Lentz | J. Bryant | Janette Walters